Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.61
-0.20 (-3.01%)
Jul 15, 2025, 4:00 PM - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $437.96 million as of July 16, 2025. Its market cap has increased by 19.96% in one year.
Market Cap
437.96M
Enterprise Value
781.28M
1-Year Change
19.96%
Ranking
Category
Stock Price
$6.61
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $437.96M, a decrease of -38.62%. That is a compound annual growth rate of -10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 437.96M | -36.19% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |